<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
 <url>
    <loc>https://www.keytruda.com/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
 <url>
    <loc>https://www.keytruda.com/qlex/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.9</priority>
  </url> 
  <url>
    <loc>https://www.keytruda.com/infusion-information-and-treatment-resources/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url> 
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-muscle-invasive-bladder-cancer/clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/melanoma/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/melanoma/stage-2B-and-stage-2C/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/melanoma/stage-3/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/melanoma/advanced/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/monotherapy-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/head-and-neck-cancer/clinical-trial-results-with-chemotherapy/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/cervical-cancer/clinical-trials-previously-treated/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/esophageal-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/treatment-options/adjuvant/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/side-effects/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/head-and-neck-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/treatment-options/high-risk-early-stage-tnbc/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/cervical-cancer/combination-therapy-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-muscle-invasive-bladder-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/adjuvant-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-urothelial-bladder-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/head-and-neck-cancer/clinical-trial-results-before-and-after-surgery/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/patient-stories/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/taking-keytruda/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/combination-therapy-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/cervical-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/squamous-combination-therapy-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-urothelial-bladder-cancer/clinical-trial-results-with-enfortumab-vedotin/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-urothelial-bladder-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/how-does-keytruda-work/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/keytruda-clinical-trials-previously-treated/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/cervical-cancer/stage-3-to-4a-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/combination-therapy-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/head-and-neck-cancer/monotherapy-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/clinical-trial-results/advanced-tnbc/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/treatment-options/advanced-nsclc/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/adjuvant-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/treatment-options/advanced-tnbc/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-urothelial-bladder-cancer/previously-treated-clinical-trials/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/keytruda-faq/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/financial-support/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/clinical-trial-results/high-risk-early-stage-tnbc/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/triple-negative-breast-cancer/high-risk-early-stage-tnbc-patient-stories/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/gastric-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-endometrial-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/early-stage-clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/treatment-options/advanced-treatment/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-urothelial-bladder-cancer/clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-endometrial-cancer/clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/head-and-neck-cancer/clinical-trial-results-after-chemotherapy/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-muscle-invasive-bladder-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/muscle-invasive-bladder-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/muscle-invasive-bladder-cancer/clinical-trial-results/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/muscle-invasive-bladder-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-endometrial-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/non-small-cell-lung-cancer/treatment-options/early-stage/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/kidney-cancer/treatment-options/adjuvant-treatment/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/msi-h-dmmr-colorectal-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-endometrial-cancer/clinical-trial-results-with-carboplatin-and-paclitaxel/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/advanced-endometrial-cancer/clinical-trial-results-after-chemotherapy/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/urothelial-bladder-cancer/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/urothelial-bladder-cancer/treatment-options/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/patient-and-caregiver-resources/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.keytruda.com/sitemap/</loc>
    <lastmod>2026-01-28</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
</urlset>
